Philips, BioIntelliSense Receive $2.8M DoD Award To Validate Wearable For Early COVID-19 Detection

Royal Philips and Denver, CO-based BioIntelliSense said they have been awarded nearly $2.8m from the US Department of Defense (DoD) through a Medical Technology Enterprise Consortium award. The monies will be used to fund a virtual clinical trial that seeks to validate the start-ups’ medical-grade wearable sensor – called BioSticker – for early detection of COVID-19-like symptoms.

Working with the University of Colorado Anschutz Medical Center, BioIntelliSense plans to enroll 2,500 participants from across the US with a recent, known COVID-19 exposure or who are experiencing COVID-19-like...